Gallagher Cam 4
4 · Zentalis Pharmaceuticals, Inc. · Filed May 31, 2024
Insider Transaction Report
Form 4
Gallagher Cam
Director
Transactions
- Sale
Common Stock
2024-05-31$11.98/sh−9,597$114,972→ 633,680 total
Footnotes (1)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.